Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prenatal and preconception population carrier screening for cystic fibrosis in Australia: Where are we up to?

Prenatal and preconception population carrier screening for cystic fibrosis in Australia: Where... Aims To describe prenatal and preconception population carrier screening for cystic fibrosis (CF) in Australia and consider progress towards establishing a universal program. Method Medline and Embase databases (1989–2013) were searched for all publications with Australian data. Existing programs for CF carrier screening in Australia were reviewed and professional peak body websites accessed to determine recommendations. Results Twenty‐two studies met the inclusion criteria. Key stakeholder groups believe that prenatal and preconception carrier screening for CF should be available. Health‐economic analyses support that CF carrier screening can be cost‐effective. There are small programs for CF carrier screening, in Victoria, New South Wales and Queensland. The Human Genetics Society of Australasia (HGSA) specifically recommend that screening be offered to women and couples planning a pregnancy and in the early stages of pregnancy. Other peak bodies indirectly endorse the availability of CF carrier screening. Barriers to screening include not being offered screening, the cost of testing, inequity of access and an incorrect perception that not having a family history of CF lowers risk. Conclusions There is support for prenatal and preconception CF carrier screening by the community, health professionals and peak professional bodies in Australia. The barriers to development of a national screening program could be overcome with greater physician engagement and government support. Implications In the interest of equity, government funded testing should be routinely offered to all pregnant women and couples planning a pregnancy. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Australian and New Zealand Journal of Obstetrics and Gynaecology Wiley

Prenatal and preconception population carrier screening for cystic fibrosis in Australia: Where are we up to?

Download PDF
7 pages

Loading next page...
 
/lp/wiley/prenatal-and-preconception-population-carrier-screening-for-cystic-g0WqDaCOxA

References (47)

Publisher
Wiley
Copyright
ANZJOG © 2014 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists
ISSN
0004-8666
eISSN
1479-828X
DOI
10.1111/ajo.12255
pmid
25350764
Publisher site
See Article on Publisher Site

Abstract

Aims To describe prenatal and preconception population carrier screening for cystic fibrosis (CF) in Australia and consider progress towards establishing a universal program. Method Medline and Embase databases (1989–2013) were searched for all publications with Australian data. Existing programs for CF carrier screening in Australia were reviewed and professional peak body websites accessed to determine recommendations. Results Twenty‐two studies met the inclusion criteria. Key stakeholder groups believe that prenatal and preconception carrier screening for CF should be available. Health‐economic analyses support that CF carrier screening can be cost‐effective. There are small programs for CF carrier screening, in Victoria, New South Wales and Queensland. The Human Genetics Society of Australasia (HGSA) specifically recommend that screening be offered to women and couples planning a pregnancy and in the early stages of pregnancy. Other peak bodies indirectly endorse the availability of CF carrier screening. Barriers to screening include not being offered screening, the cost of testing, inequity of access and an incorrect perception that not having a family history of CF lowers risk. Conclusions There is support for prenatal and preconception CF carrier screening by the community, health professionals and peak professional bodies in Australia. The barriers to development of a national screening program could be overcome with greater physician engagement and government support. Implications In the interest of equity, government funded testing should be routinely offered to all pregnant women and couples planning a pregnancy.

Journal

Australian and New Zealand Journal of Obstetrics and Gynaecology – Wiley

Published: Jan 1, 2014

Keywords: ; ;

There are no references for this article.